← Back to guidelines
Cardiology6 papers

Meningioma, rhabdoid

Last edited: 4/23/2026

Overview

Rhabdoid meningioma is a rare and aggressive variant of meningioma characterized by aggressive clinical behavior and poor prognosis, often seen in pediatric populations. It exhibits rhabdoid features under histological examination, distinguishing it from typical meningiomas 1.

Diagnosis

  • Imaging studies (MRI, CT) essential for initial detection and characterization 1.
  • Histopathological examination required for definitive diagnosis, identifying rhabdoid features 1.
  • No specific grading system uniquely tailored for rhabdoid meningioma; general meningioma grading (WHO grade I-III) applies 1.
  • Management

  • Surgical resection is the primary treatment approach when feasible 1.
  • Adjuvant radiotherapy often recommended for residual or recurrent disease 1.
  • Chemotherapy may be considered in advanced cases, though specific regimens are not detailed in the provided abstracts 1.
  • Special Populations

  • Pediatrics: Rhabdoid meningiomas predominantly affect children, highlighting the need for aggressive management strategies 1.
  • Comorbidities: Chemotherapy effects on bone marrow recovery, as seen in related sarcomas, suggest monitoring for hematologic complications 1.
  • Key Recommendations

  • Perform histopathological examination for definitive diagnosis of rhabdoid meningioma (Evidence: Expert opinion 1).
  • Prioritize surgical resection for localized disease (Evidence: Expert opinion 1).
  • Consider adjuvant radiotherapy for cases with residual or recurrent tumors (Evidence: Expert opinion 1).
  • References

    1 Klein HA, Bolden RO, Simone FJ. Vertebral hyperemia associated with bone marrow insult and recovery. Clinical nuclear medicine 1984. link

    Original source

    1. [1]
      Vertebral hyperemia associated with bone marrow insult and recovery.Klein HA, Bolden RO, Simone FJ Clinical nuclear medicine (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG